Study on Prognosis of Acutely Ruptured Intracranial Aneurysms

Recruiting Observational Study
Aneurysmal Subarachnoid Hemorrhage Endovascular Procedures Craniotomy Patient Outcome Assessment Treatment Outcome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
880 (estimated)
Sponsor
Haaglanden Medical Centre · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The SPARTA study is a prospective multicenter observational trial in the Netherlands with the aim of identifying the best clinical care in patients with aneurysmal subarachnoidal haemorrhage. Differences in outcome between surgical treatment and endovascular treatment will be explored. Furthermore, cost effectiveness and radiological prognostic factors will be examined.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Confirmed diagnosis of subarachnoid haemorrhage on CT-scan or lumbar puncture (in the presence of a negative CT-scan) * Intracranial aneurysm proven within 6 months to be the cause of subarachnoid haemorrhage * Age 18 years or over at presentation. * Written informed consent …
Contacts

Rick Vreeburg, MD

+31(0)88-9792165

r.j.g.vreeburg@lumc.nl

CONTACT

Wouter Moojen, MD, PhD

w.moojen@haaglandenmc.nl

CONTACT